A cleavable disulfide linker
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Aminoethyl-SS-Propionic Acid

Item No. 35501

Technical Information
Formal Name
3-[(2-aminoethyl)dithio]-propanoic acid
CAS Number
15579-00-7
Molecular Formula
C5H11NO2S2
Formula Weight
Purity
≥95%
A solid
DMF: 16 mg/mlDMSO: 11 mg/mlEthanol: Slightly solublePBS (pH 7.2): 5 mg/ml
SMILES
O=C(CCSSCCN)O
InChi Code
InChI=1S/C5H11NO2S2/c6-2-4-10-9-3-1-5(7)8/h1-4,6H2,(H,7,8)
InChi Key
HMMFDEBVQNRZLJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Aminoethyl-SS-propionic acid is a cleavable disulfide linker.1,2 It has been used in the synthesis of antibody-drug conjugates (ADCs) containing the antibody trastuzumab and a membrane-impermeable cytotoxin, which inhibits HER2 dimerization and induces cytotoxicity in HER2-positive breast cancer cells, respectively.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Beck, A., Goetsch, L., Dumontet, C., et alStrategies and challenges for the next generation of antibody-drug conjugates. Nat. Rev. Drug Discov. 16(5), 315-337 (2017).

    2. Knewtson, K.E., Perera, C., Hymel, D., et alAntibody-drug conjugate that exhibits synergistic cytotoxicity with an endosome-disruptive peptide. ACS Omega 4(7), 12955-12968 (2019).